XML 124 R93.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring Activities - Additional Information - Graphite Bio, Inc. (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Feb. 28, 2023
Dec. 31, 2023
Dec. 31, 2022
Aug. 31, 2023
Aug. 01, 2023
Dec. 16, 2021
Restructuring Cost and Reserve [Line Items]            
Reduction in force, percentage 50.00%          
Employees Retention Bonus Payable   $ 4,200        
Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Restructuring and impairment costs   62,081 $ 0      
Recognized termination benefits   1,000        
Termination benefits paid   600        
Employees Retention Bonus Accrued   3,700        
Non cash impairment of assests   $ 46,900        
Restructuring Plan | Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Reduction in force, percentage   50.00%        
Restructuring and impairment costs   $ 3,400        
Second Restructuring Plan [Member] | Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Restructuring and impairment costs   3,500        
Recognized termination benefits   1,000        
Retention Bonuses   3,200        
Restructuring and impairment charges   $ 7,000        
Second Restructuring Plan [Member] | Minimum | Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Reduction in force, percentage   33.10%        
Second Restructuring Plan [Member] | Maximum | Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Reduction in force, percentage   78.10%        
Bayside Lease | Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Term of contract       20 months 20 months 120 months
Sublease payments       $ 500 $ 500  
Asset Purchase Agreement (APA) | Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Exchange Amount Of Asset   $ 500        
Additional contingent consideration   1,000        
Reimbursement of research and development amount   $ 600        
LOA to Acquire Nula-Cel Assets | Graphite Bio, Inc.            
Restructuring Cost and Reserve [Line Items]            
Equity interested diluted percentage   20.00%